Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Epilepsy Treatment Drugs Market
Epilepsy Treatment Drugs Market Size
- Report ID: GMI7730
- Published Date: Dec 2023
- Report Format: PDF
Epilepsy Treatment Drugs Market Size
Epilepsy Treatment Drugs Market was valued at USD 8.3 billion in 2023 and is expected to grow at over 4.6% CAGR between 2024 and 2032. The key drivers propelling the expansion of the market involve the surge in recent approvals for new medications and the escalating prevalence of epilepsy globally.
According to the World Health Organization's update in February 2023, approximately 50 million individuals suffer with epilepsy, establishing it as one of the prevailing neurological conditions worldwide. Also, nearly 80% of the affected belong to the low and middle-income countries. Therefore, the significant prevalence and impact of epilepsy has surged the critical need for efficient treatment, thereby anticipating an opportunistic factor for market expansion.
Epilepsy treatment drugs are pharmaceutical agents designed to manage and mitigate the symptoms of epilepsy; a neurological disorder characterized by recurrent seizures. These drugs aim to prevent or reduce the frequency and intensity of seizures. The selection and administration of antiepileptic drugs are tailored to the specific type of epilepsy and individual patient characteristics.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Epilepsy Treatment Drugs Market Size in 2023: | USD 8.3 Billion |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 4.6% |
| 2032 Value Projection: | USD 12.3 Billion |
| Historical Data for: | 2018 to 2023 |
| No. of Pages: | 220 |
| Tables, Charts & Figures: | 373 |
| Segments covered: | Drug Class, Type, Route of Administration, Age Group, Seizure Type, Distribution Channel, & Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Epilepsy Treatment Drugs Market Scope
